Repeat Orders

Pre-roll joint market provides multiple growth opportunities for Creso

Finfeed Archived Apr 08, 2021

Creso Pharma's (ASX: CPH) wholly-owned Canadian subsidiary, Mernova Medicinal has secured new purchase orders valued at C$145,192